全文获取类型
收费全文 | 1496096篇 |
免费 | 112072篇 |
国内免费 | 3010篇 |
专业分类
耳鼻咽喉 | 21269篇 |
儿科学 | 46020篇 |
妇产科学 | 40633篇 |
基础医学 | 223881篇 |
口腔科学 | 43664篇 |
临床医学 | 133054篇 |
内科学 | 282730篇 |
皮肤病学 | 31633篇 |
神经病学 | 113838篇 |
特种医学 | 58149篇 |
外国民族医学 | 242篇 |
外科学 | 229157篇 |
综合类 | 37680篇 |
现状与发展 | 3篇 |
一般理论 | 408篇 |
预防医学 | 113392篇 |
眼科学 | 35538篇 |
药学 | 113550篇 |
3篇 | |
中国医学 | 3784篇 |
肿瘤学 | 82550篇 |
出版年
2018年 | 14412篇 |
2016年 | 12653篇 |
2015年 | 14452篇 |
2014年 | 20245篇 |
2013年 | 30604篇 |
2012年 | 40945篇 |
2011年 | 43061篇 |
2010年 | 25349篇 |
2009年 | 23831篇 |
2008年 | 40505篇 |
2007年 | 44039篇 |
2006年 | 44157篇 |
2005年 | 42509篇 |
2004年 | 41680篇 |
2003年 | 39912篇 |
2002年 | 38590篇 |
2001年 | 67635篇 |
2000年 | 69004篇 |
1999年 | 57724篇 |
1998年 | 16317篇 |
1997年 | 14479篇 |
1996年 | 14615篇 |
1995年 | 13850篇 |
1994年 | 13094篇 |
1992年 | 47129篇 |
1991年 | 46481篇 |
1990年 | 45569篇 |
1989年 | 44503篇 |
1988年 | 41160篇 |
1987年 | 40159篇 |
1986年 | 38237篇 |
1985年 | 36649篇 |
1984年 | 27760篇 |
1983年 | 23672篇 |
1982年 | 14136篇 |
1981年 | 12852篇 |
1980年 | 12192篇 |
1979年 | 27036篇 |
1978年 | 19390篇 |
1977年 | 16393篇 |
1976年 | 15354篇 |
1975年 | 16750篇 |
1974年 | 20353篇 |
1973年 | 19464篇 |
1972年 | 18444篇 |
1971年 | 17157篇 |
1970年 | 16429篇 |
1969年 | 15655篇 |
1968年 | 14222篇 |
1967年 | 12999篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Amosova E. N. Shilova I. V. Zueva E. P. Rybalkina O. Yu. 《Pharmaceutical Chemistry Journal》2020,54(7):721-724
Pharmaceutical Chemistry Journal - Three extracts were produced from the above-ground part of the meadowsweet Filipendula ulmaria (L.) Maxim. using water, 40% ethanol, and 70% ethanol. Comparative... 相似文献
33.
Nevo N. Goldstein A. L. Staierman M. Eran N. Carmeli I. Rayman S. mnouskin Y. 《Hernia》2022,26(6):1491-1499
Hernia - The minimally invasive surgical repair of combined inguinal and ventral hernias often requires shifting from one approach or plane to another. The traditional enhanced-view totally... 相似文献
34.
目的探讨维生素D(VitD)联合鱼油对糖尿病前期(PDM)患者糖脂代谢、胰岛β细胞功能的影响。 方法选取PDM患者132例,随机均分为联合组(VitD+鱼油)、VitD组(VitD)和对照组(不干预)。比较各组糖脂代谢、胰岛β细胞功能、炎症反应、血管内皮功能等指标。 结果与干预前比较,干预后联合组甘油三酯降低,白细胞介素-10增高(P<0.05),联合组和VitD组低密度脂蛋白胆固醇、肿瘤坏死因子-α、胰岛素抵抗指数、前列腺素E2、瘦素、抵抗素降低(P<0.05),空腹胰岛素、胰岛β细胞功能指数、脂联素增高(P<0.05),且联合组改善更为明显(P<0.05)。 结论维生素D联合鱼油治疗PDM患者可改善其脂代谢和胰岛功能相关指标,具有一定临床应用价值。 相似文献
35.
Koel Dutt P N Agarwal Rajdeep Singh Vikas Singh Tomar 《The Indian journal of surgery》2015,77(1):62-64
Haemophilia is a common cause of genetically inherited bleeding disorders. Pseudotumours occur in 1–2 % of persons with severe forms of haemophilia. These are a result of repeated haemorrhage into soft tissues, subperiosteum or a site of bone fracture with inadequate resorption of the extravasated blood. There are a number of therapeutic alternatives for this dangerous condition: surgical removal, percutaneous management, irradiation, embolization etc. In this case report, we describe the natural history, clinical course and successful surgical management of a patient with haemophilia who presented with a massive pseudotumour. We also briefly review the relevant literature on the various therapeutic modalities that have been implemented in the management of this rare complication. Though surgeons may be averse to operate on haemophiliacs, primary surgical management as done in our case may prove to be the definitive treatment option for such patients. 相似文献
36.
37.
38.
39.
40.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献